Carey John F 4

Accession 0000899243-22-037665

CIK 0001756262other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:33 PM ET

Size

29.6 KB

Accession

0000899243-22-037665

Insider Transaction Report

Form 4

Period: 2022-12-01

TransMedics Group, Inc.TMDX

Carey John F

VP of Operations

Transactions

Exercise/Conversion
Common Stock
2022-12-02$0.28/sh+6,237$1,746→ 7,008 total
Exercise/Conversion
Common Stock
2022-12-02$0.28/sh+6,800$1,904→ 13,808 total
Exercise/Conversion
Common Stock
2022-12-02$38.46/sh+10,000$384,600→ 23,808 total
Sale
Common Stock
2022-12-02$63.50/sh−10,000$635,000→ 13,808 total
Sale
Common Stock
2022-12-01$60.83/sh−1,497$91,063→ 2,274 total
Exercise/Conversion
Common Stock
2022-12-01$0.28/sh+3,000$840→ 3,771 total
Sale
Common Stock
2022-12-01$61.70/sh−1,403$86,565→ 871 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-12-02−6,237→ 36 total
Exercise: $0.28Exp: 2023-05-29→ Common Stock (6,237 underlying)
Sale
Common Stock
2022-12-01$62.45/sh−100$6,245→ 771 total
Exercise/Conversion
Common Stock
2022-12-05$0.28/sh+36$10→ 13,844 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-12-01−3,000→ 6,273 total
Exercise: $0.28Exp: 2023-05-29→ Common Stock (3,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-12-02−10,000→ 15,000 total
Exercise: $38.46Exp: 2031-02-24→ Common Stock (10,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-12-02−6,800→ 0 total
Exercise: $0.28Exp: 2023-03-27→ Common Stock (6,800 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2022-12-05−36→ 0 total
Exercise: $0.28Exp: 2023-05-29→ Common Stock (36 underlying)

Footnotes (6)

[F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $60.23 to $61.22, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
[F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $61.29 to $61.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
[F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $63.50 to $63.55, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
[F5]The option is fully vested.
[F6]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TransMedics Group, Inc.

CIK 0001756262

→

Entity typeother

Related Parties

filerCIK 0001774272

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 5:33 PM ET
Size: 29.6 KB

View on SEC.gov